Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Maintains Market Perform on Splunk, Lowers Price Target to $95

Cowen & Co. Maintains Market Perform on Splunk, Lowers Price Target to $95

Cowen & Co. analyst J. Derrick Wood maintains Splunk (NASDAQ:SPLK) with a Market Perform and lowers the price target from $110 to $95.

byBenzinga Newsdesk

August 25, 2022

1 minute read

Cowen & Co. analyst J. Derrick Wood maintains Splunk (NASDAQ:SPLK) with a Market Perform and lowers the price target from $110 to $95.

Analyst Ratings

Expert Ratings for Taiwan Semiconductor

By Benzinga Insights

June 1, 1:01 PM

Over the past 3 months, 5 analysts have published their opinion on Taiwan Semiconductor (NYSE:TSM) stock. These analysts…

TSM

Mr. John J. Ray III, CEO Of FTX, Issues Testimony To House Financial Services Committee

By Benzinga Newsdesk

December 12, 2:38 PM

https://docs.house.gov/meetings/BA/BA00/20221213/115246/HHRG-117-BA00-Wstate-RayJ-20221213.pdf

BTC

New DEX Ruler In Town: dYdX Takes Over Uniswap With $757M Daily Volume

By Mehab Qureshi

January 18, 4:09 AM

The decentralized exchange, dYdX (CRYPTO: ETHDYDX), has outperformed Uniswap (CRYPTO: UNI), becoming the dominant decentralized exchange (DEX) by daily trading volume.

$UNI

FDA Signals Shortage For Teva Pharma’s ADHD Drug Due To Manufacturing Delay

By Vandana Singh

October 13, 6:25 AM

The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA).

TEVA

Cowen & Co. Maintains Market Perform on Splunk, Lowers Price Target to $95

Related Posts

Expert Ratings for Taiwan Semiconductor

Mr. John J. Ray III, CEO Of FTX, Issues Testimony To House Financial Services Committee

New DEX Ruler In Town: dYdX Takes Over Uniswap With $757M Daily Volume

FDA Signals Shortage For Teva Pharma’s ADHD Drug Due To Manufacturing Delay